Murray Bornstein
Murray B. Bornstein (November 22, 1917 – August 31, 1995) was an American neuroscientist. He was well known for developing tissue culture techniques valuable for studying demyelinating disease.[1] He collaborated with the Weizmann Institute and Teva Pharmaceuticals to develop the drug Copaxone, now a common treatment for multiple sclerosis.[2][3]
In 2014, the Geisel School of Medicine at Dartmouth College established a chaired professorship, relating to research specialty in neurology and multiple sclerosis, in his honor.[4]
References[]
- ^ Bornstein, Murray (1981). "Tissue culture techniques applied to demyelinating disease". Trends in Neurosciences. 4: 237–240. doi:10.1016/0166-2236(81)90074-6. Retrieved 4 March 2017.
- ^ Pace, Eric (6 September 1995). "M. B. Bornstein, 77; Known for Research In Multiple Sclerosis". The New York Times. Retrieved 4 March 2017.
- ^ "aspetjournals.org". Archived from the original on 2011-05-08.
- ^ "Pachner Named Murray B. Bornstein Professor". 13 June 2014. Retrieved 4 March 2017.
| hide Authority control  | |
|---|---|
| General | |
| National libraries | |
  | This article about a biologist from the United States is a stub. You can help Wikipedia by . |
Categories:
- American neuroscientists
- Medical educators
- 1917 births
- 1995 deaths
- American biologist stubs